Professional Documents
Culture Documents
Clozapine
Clozapine
Indications
Treatment resistant schizophrenia (main indication)
Tardive dyskinesia
Psychosis in Parkinsons disease
Huntingtons psychosis
Resistant mania
NICE guidelines
Clozapine should be used in treatment resistant schizophrenia where there has
been a lack of a satisfactory clinical improvement despite the sequential use of
the recommended doses for 6 weeks to 8 weeks of at least two antipsychotics at
least one of which should be an atypical
Mode of action
Clozapine mainly blocks D1 and D4 receptors its effects on D2 receptors are less
than traditional antipsychotics. The lower affinity of Clozapine for D 2 receptors
may partially explain its lack of EPSEs and hyperprolactinaemia
The superior efficacy of Clozapine in treating resistant schizophrenia may be due
to its additional blockade of 5-HT2 receptors
1
Dr Diane Mullins, RCSI Tutor in Psychiatry, St Itas Hospital, Portrane
Side effectsassociated with an extremely low incidence of EPSEs
Common side effects
o Anticholinergic: constipation, dry mouth, blurred vision, urinary retention
o Anti-adrenergic: hypotension, sexual dysfunction
o Other: sedation, weight gain, nausea, vomiting, hypersalivation, tachycardia,
hypertension, drowsiness, dizziness, headaches
Less common
o Seizures (dose related)
o Fainting
o Gastric discomfort
o Small involuntary muscle contractions
o Periodic catalepsy
o Enuresis
Rarer or potentially life-threatening
o Agranulocytosis (incidence: 0.8%) risk in older age & females
o Neutropenia (incidence: 3%)
o Thrombocytopenia
o Impaired temperature regulation, fever
o Dysphagia
o Circulatory collapse, arrhythmias, myocarditis, cardiomyopathy, pericarditis,
pericardial effusion, thromboembolism
o Pulmonary embolism
o Confusion, delirium
o Pancreatitis
o Pneumonia
o Neuroleptic malignant syndrome (NMS)